VRTX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vertex Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 8 176.21 MXN -1.04%

Market Cap: Mex$109.5B

V	Vertex Pharmaceuticals Inc BMV:VRTX	US
B	Booking Holdings Inc XMUN:PCE1	US
U	Unilever PLC AEX:UNA	UK
M	Microsoft Corp F:MSF	US
	Columbia Banking System Inc NASDAQ:COLB	US
C	Ciena Corp DUS:CIE1	US
	United Airlines Holdings Inc NASDAQ:UAL	US
	Verisk Analytics Inc LSE:0LP3	US
	NAPCO Security Technologies Inc F:NS1	US
	Equifax Inc NYSE:EFX	US
E	Emerson Electric Co SWB:EMR	US
	Roper Technologies Inc SIX:ROP	US
	Schneider Electric SE OTC:SBGSF	FR
	Addus Homecare Corp NASDAQ:ADUS	US
N	Norwegian Cruise Line Holdings Ltd F:1NC	US
	LiveOne Inc F:351	US
S	STINAG Stuttgart Invest AG XMUN:STG	DE

Profitability Summary

Vertex Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

86%

Declining Gross Margin

88% > 86%

Exceptional Operating Margin

39%

Strong 3Y Average Operating Margin

41%

Declining Operating Margin

47% > 39%

Exceptional Net Margin

36%

Sustainable 3Y Average Net Margin

20%

Net Margin is Increasing

35% > 36%

Exceptional Free Cash Flow Margin

30%

Strong 3Y Average Free Cash Flow Margin

16%

Declining Free Cash Flow Margin

41% > 30%

Positive ROE

24%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.